Quincy, MA – June 14, 2013 – Myriant Corporation today announced its planned participation at the 10th Annual World Congress on Industrial Biotechnology in Montréal, Canada.
The 10th Annual World Congress on Industrial Biotechnology will take place at the Palais des congrès de Montréal in Montréal, Canada.
Myriant is a global leader innovating and commercializing bio-based chemical intermediates. Myriant enables its customers to achieve their sustainability initiatives by utilizing renewable feedstocks to produce high-value, cost-advantaged chemicals, including bio-succinic acid and its derivatives. Myriant is currently commercializing its bio-succinic acid platform from two operating chemical plants: The first is Myriant's flagship plant in Lake Providence, LA; the other, a commercial validation facility located in Leuna, Germany, which is operated by Myriant's global partner, ThyssenKrupp Uhde. Myriant, together with Johnson Matthey - Davy Technologies (JM Davy), combined the efficiencies of their respective chemical processes for the production of cost-competitive bio-BDO and bio-THF made from Myriant's bio-succinic acid, yielding overall carbon efficiency of 87%. Myriant is also advancing its proprietary, low-cost, high-purity process for bio-acrylic acid. Myriant commercialized D(-) lactic acid in 2008 for the production of polylactic acid (PLA), which is used to make biodegradable plastic. More information about Myriant's pipeline of renewable chemicals can be found at www.myriant.com. Myriant is a 2013 Red Herring Top 100 Company in North America.
Sue Hager SVP, Corporate Communications and Government Affairs